EPH-EPHRIN in human gastrointestinal cancers

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 12

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

575

HTML

3523

Figures (1-1)

580

Tables (1-3)

426

Sum=5104

Dec 15, 2010 (publication date) through Feb 21, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastrointest Oncol. Dec 15, 2010; 2(12): 421-428
Published online Dec 15, 2010. doi: 10.4251/wjgo.v2.i12.421

Table 3 Receptors and ligands corresponding

x indicates a known interaction. Each binding constant is shown in the reference Bowden et al[27]. EPH: Erythropoietin-producing hepatoma.

Citation: Sugimura H, Wang JD, Mori H, Tsuboi M, Nagura K, Igarashi H, Tao H, Nakamura R, Natsume H, Kahyo T, Shinmura K, Konno H, Hamaya Y, Kanaoka S, Kataoka H, Zhou XJ. EPH-EPHRIN in human gastrointestinal cancers. World J Gastrointest Oncol 2010; 2(12): 421-428
URL: https://www.wjgnet.com/1948-5204/full/v2/i12/421.htm
DOI: https://dx.doi.org/10.4251/wjgo.v2.i12.421